Dermatomyositis+1
RecruitingStudy on Anifrolumab for Adults with Polymyositis or Dermatomyositis
Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis
- Disease:DermatomyositisPolymyositis
Bulgaria- Participants:18–64 years · 65+ years
Study on Anifrolumab for Adults with Polymyositis or Dermatomyositis
BulgariaStudy of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease
BulgariaStudy on the Long-Term Safety of Dazukibart in Patients with Idiopathic Inflammatory Myopathies, Including Dermatomyositis and Polymyositis
BulgariaStudy on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis
BulgariaA study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe
BulgariaStudy on the Effects of Casimersen and Golodirsen for Patients with Duchenne Muscular Dystrophy Amenable to Exon 45 or 53 Skipping
BulgariaStudy on the Effects of ATL1102 for Nonambulatory Patients with Duchenne Muscular Dystrophy
BulgariaStudy on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy
BulgariaStudy on the Effects of GLPG3667 for Adults with Dermatomyositis
Bulgaria